Spotlight on Genting Berhad in this week’s Corporate Profile by Trushna.

Genting-IPO15

Report from RHB Research (3 March 2016) include link to the prospect of IPO of the pharmaceutical unit of Genting Berhad. With good Phase 3 result of experimental Alzheimer’s drug coming in July, the indicative IPO value is said to be USD$15 billion. How will this affect the share price of Genting Berhad?

Watch this video to find out more.